BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Press Releases

  Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor

  July 29, 2024

   · 

  6 min read
• Press Releases

  Petros Pharmaceuticals’ Pivotal Statistically Significant Self Selection Study Shows Stronger Results with Proprietary Technology Application as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)

  July 29, 2024

   · 

  11 min read
• Press Releases

  Health Canada Authorizes Vabysmo® (faricimab injection) for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion

  July 29, 2024

   · 

  8 min read
• Press Releases

  Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting

  July 29, 2024

   · 

  3 min read
• Press Releases

  Zealand Pharma Appoints Eric Cox as Chief Commercial Officer

  July 29, 2024

   · 

  5 min read
• Drug Development

  Menarini Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Efficacy, Safety and Tolerability of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia

  July 29, 2024

   · 

  8 min read
• Press Releases

  Cipher Pharmaceuticals Acquires Profitable Growth Dermatology Products from ParaPRO for US$89.5 Million

  July 29, 2024

   · 

  11 min read
• Press Releases

  Priovant Therapeutics Announces Completion of Enrollment in Global Phase 3 Study Evaluating Brepocitinib in Dermatomyositis (VALOR)

  July 29, 2024

   · 

  7 min read
• Press Releases

  Endo Releases Annual Corporate Responsibility Report

  July 29, 2024

   · 

  4 min read
• Press Releases

  Interpace Diagnostics® Announces Undefined Extension of Medicare Coverage for PancraGEN®, a Molecular Diagnostic Test That Assesses Cancer Risk of Pancreatic Cysts

  July 29, 2024

   · 

  6 min read